BI-847325
95%
- Product Code: 57604
CAS:
1207293-36-4
| Molecular Weight: | 464.56 g./mol | Molecular Formula: | C₂₉H₂₈N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
BI-847325 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of MEK and Aurora kinases, which are crucial in cell cycle regulation and tumor growth. By targeting these kinases, it aims to disrupt the proliferation of cancer cells and induce apoptosis. Its application is most relevant in preclinical studies for treating various cancers, including solid tumors and hematologic malignancies. Researchers are exploring its efficacy in combination with other anticancer agents to enhance therapeutic outcomes and overcome drug resistance.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿5,553.00 |
+
-
|
BI-847325
BI-847325 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of MEK and Aurora kinases, which are crucial in cell cycle regulation and tumor growth. By targeting these kinases, it aims to disrupt the proliferation of cancer cells and induce apoptosis. Its application is most relevant in preclinical studies for treating various cancers, including solid tumors and hematologic malignancies. Researchers are exploring its efficacy in combination with other anticancer agents to enhance therapeutic outcomes and overcome drug resistance.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :